甘肃医药
甘肅醫藥
감숙의약
Gansu Medical Journal
2015年
4期
249-252
,共4页
心先安%重症充血性心力衰竭%心脏功能
心先安%重癥充血性心力衰竭%心髒功能
심선안%중증충혈성심력쇠갈%심장공능
Heart Ann first%Severe congestive heart failure%Heart function
目的：探讨心先安治疗重症充血性心力衰竭的临床疗效。方法：连续收集2012年10月至2014年2月于我院就诊的100例重症充血性心力衰竭患者的相关资料，按照入院顺序随机分为观察组和对照组，各50例。对照组接受常规治疗，观察组在常规治疗的基础上，将180mg心先安加入250ml 10%的葡萄胎注射液中进行静脉滴注，14d后对比两组治疗效果、心功能分级、左室射血分数、心排指数等。结果：观察组治疗总有效率高于对照组，再住院率低于对照组，差异具有统计学意义（P＜0.05）；治疗后，观察组患者心功能分级、血压、HR、左室射血分数（left ventricular ejection fraction，LVEF）、心排指数（cardiac index，CI）、左室短轴缩短率（fraction shortening，FS）、心脏每搏量（stroke volume，SV）等均优于对照组，差异具有显著性（P＜0.05）；观察组6min步行距离较对照组明显延长（P＜0.05）。结论：心先安可改善重症充血性心衰患者心功能，降低再住院率。
目的：探討心先安治療重癥充血性心力衰竭的臨床療效。方法：連續收集2012年10月至2014年2月于我院就診的100例重癥充血性心力衰竭患者的相關資料，按照入院順序隨機分為觀察組和對照組，各50例。對照組接受常規治療，觀察組在常規治療的基礎上，將180mg心先安加入250ml 10%的葡萄胎註射液中進行靜脈滴註，14d後對比兩組治療效果、心功能分級、左室射血分數、心排指數等。結果：觀察組治療總有效率高于對照組，再住院率低于對照組，差異具有統計學意義（P＜0.05）；治療後，觀察組患者心功能分級、血壓、HR、左室射血分數（left ventricular ejection fraction，LVEF）、心排指數（cardiac index，CI）、左室短軸縮短率（fraction shortening，FS）、心髒每搏量（stroke volume，SV）等均優于對照組，差異具有顯著性（P＜0.05）；觀察組6min步行距離較對照組明顯延長（P＜0.05）。結論：心先安可改善重癥充血性心衰患者心功能，降低再住院率。
목적：탐토심선안치료중증충혈성심력쇠갈적림상료효。방법：련속수집2012년10월지2014년2월우아원취진적100례중증충혈성심력쇠갈환자적상관자료，안조입원순서수궤분위관찰조화대조조，각50례。대조조접수상규치료，관찰조재상규치료적기출상，장180mg심선안가입250ml 10%적포도태주사액중진행정맥적주，14d후대비량조치료효과、심공능분급、좌실사혈분수、심배지수등。결과：관찰조치료총유효솔고우대조조，재주원솔저우대조조，차이구유통계학의의（P＜0.05）；치료후，관찰조환자심공능분급、혈압、HR、좌실사혈분수（left ventricular ejection fraction，LVEF）、심배지수（cardiac index，CI）、좌실단축축단솔（fraction shortening，FS）、심장매박량（stroke volume，SV）등균우우대조조，차이구유현저성（P＜0.05）；관찰조6min보행거리교대조조명현연장（P＜0.05）。결론：심선안가개선중증충혈성심쇠환자심공능，강저재주원솔。
Objective: To explore the heart Ann first clinical curative effect for the treatment of severe congestive heart failure. Methods: Collection in October 2012 to February 2014 in our hospital during the period of 100 patients with severe congestive heart failure related information, according to admission order were randomly divided into observation group and control group, 50 cases each. Control group accepted routine treatment, the observation group based on this intention to 180 mg of Ann to join 10%hydatidiform mole injection intravenous drip in 250 ml, compared two groups of treatment effect after 14 d and grade of cardiac function and left ventricular ejection fraction and cardiac index, etc. Results: Treatment group total effectiveness is higher than the observed, then the hospitalization rate is lower than the control group, the difference is statistically significant (P<0.05); After treatment, the observation group of patients with cardiac function classification, blood pressure, HR, LVEF, CI, FS and SV were superior to control group, with significant difference (P<0.05); The observation group 6 min walking distance was significantly longer (P<0.05). Conclusions: The heart first encore improves cardiac function in patients with severe congestive heart failure, reduce hospitalization rates again.
